GenoLogics, a leading developer of lab and data management software solutions for life sciences research, today announced it will work closely with London Genetics Ltd., a commercial company whose purpose is to facilitate and manage partnerships between the health care industry and centers of biomedical excellence in London, to identify opportunities for collaboration.

Rosetta Biosoftware, a leader in life science informatics solutions, today announced that the Rosetta Syllego™ system has achieved GeneChip-compatibleTM status for use with the Affymetrix microarray platform.

National Instruments (Nasdaq:NATI) and Anritsu Company today announced a joint effort to develop LabVIEW Plug and Play and LabWindows/CVI instrument drivers for Anritsu test instruments.

Rescentris, Inc. today announced the new major release of its CERF software. CERF is the leading electronic lab notebook (ELN) and scientific content management solution for multidiscipline life sciences research.

CSols, Inc. is proud to announce its partnership with Clarmon Corporation to distribute, implement and support its Compliance Management Solution, QAvalid TM .

Ocimum Biosolutions to Buy Gene Logic’s Genomics Business Combination Will Create Premiere Provider of Pharmacogenomic Data and Services

Applied Biosystems, an Applera Corporation business, and its joint venture partner, Sciex, a division of MDS Inc.’s Analytical Technologies business, today introduced a new, automated toxicology testing application designed to better identify drugs of abuse, such as cocaine, heroin and date rape drugs for forensic investigations

Thermo Fisher Scientific Inc., the world leader in serving science, announces an internal process improvement initiative within its global laboratory informatics (LIMS) line of business.

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced significant enhancements to its InForm™ Integrated Trial Management (ITM) electronic data capture (EDC) solution, delivering new electronic clinical data management (eCDM) capabilities.

Accelrys, Inc. , a leading provider of scientific business intelligence solutions, announced the release of Discovery Studio® 2.0, the most advanced modeling and simulation software environment for drug discovery available today.

Two new versions of Lab Tests Online launched in the last two weeks, marking a successful end to a year of global expansion for the award-winning patient education site.

)--Symyx Technologies, Inc. is pleased to announce enhancements to the MDL Isentris informatics system (henceforth known as Symyx Isentris), giving research organizations improved ability to speed R&D experimentation, reduce costs and improve productivity.

The partnership provides a comprehensive protocol design, management and compliant lab procedure execution platform for stability studies in a multi-site pharmaceutical quality operation. The solution integrates Autoscribe’s Stability System with VelQuest’s award winning SmartLab™ GMP Electronic Notebook System.

Accelrys, Inc. today announced the release of Materials Studio® 4.2, the newest version of its chemicals, materials and pharmaceutical development modeling and simulation platform.

Biomedical Research, Inc. (ABR), an international, full-service CRO headquartered in Princeton, New Jersey, announced today that LabPas CT is live in their production environment and will be used to automate the conduct of their Phase I trials in their 72-bed research unit.

Symyx Technologies, Inc. (Nasdaq:SMMX) and Advanced Chemistry Development (ACD/Labs) today announced the availability of no-charge add-ins to Symyx Draw (previously MDL Draw).

Chemical Computing Group Inc. (CCG) announces the general release of the software resulting from its close collaboration with BioSolveIT GmbH surrounding FlexX/FlexSIS one of the world’s fastest high-precision docking engines.

Chemical Computing Group Inc. (CCG) and Molecular Networks GmbH today announce the integration of CORINA, Molecular Networks' premium three-dimensional molecular model-generating program, into CCG's comprehensive and powerful life science modeling suite, Molecular Operating Environment (MOE).

UCB is the latest pharmaceutical company to invest in software for drug metabolism studies from LabLogic Systems.

Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that it has released a major upgrade to its best-in-class GastroPlus software for pharmaceutical research and development.